The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: rituximab     Quarter: 2016Q3

Total Records: 1,104     Number of Pages: 56

DRUGNAME PT EventCount
Rituximab Lymph node pain 8
Rituximab Lymphadenitis 8
RITUXIMAB Lymphocytosis 8
Rituximab Mass 8
Rituximab Monarthritis 8
Rituximab Muscle twitching 8
RITUXIMAB Muscular weakness 8
RITUXIMAB Neutropenic sepsis 8
Rituximab Renal impairment 8
Rituximab Subileus 8
Rituximab Superficial spreading melanoma stage unspecified 8
RITUXIMAB Therapeutic response decreased 8
RITUXIMAB Therapy non-responder 8
Rituximab Varices oesophageal 8
Rituximab Waldenstrom's macroglobulinaemia 8
Rituximab Arthropathy 7
Rituximab Bacterial sepsis 7
RITUXIMAB Blood lactate dehydrogenase increased 7
Rituximab Blood urea increased 7
Rituximab Bone marrow failure 7

Total Records: 1,104     Number of Pages: 56